Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Sei Investments Co.

Sei Investments Co. increased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 24.4% during the 1st quarter, HoldingsChannel reports. The fund owned 117,938 shares of the biotechnology company’s stock after acquiring an additional 23,148 shares during the quarter. Sei Investments Co.’s holdings in Axon Enterprise were worth $36,901,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of AXON. ICA Group Wealth Management LLC acquired a new stake in Axon Enterprise during the fourth quarter valued at approximately $26,000. Trivant Custom Portfolio Group LLC acquired a new stake in Axon Enterprise during the first quarter valued at approximately $31,000. BKM Wealth Management LLC acquired a new stake in Axon Enterprise during the fourth quarter valued at approximately $32,000. First PREMIER Bank acquired a new stake in Axon Enterprise during the first quarter valued at approximately $33,000. Finally, Key Financial Inc raised its stake in Axon Enterprise by 367.6% during the fourth quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock valued at $41,000 after buying an additional 125 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on AXON. Craig Hallum upped their price objective on Axon Enterprise from $325.00 to $370.00 and gave the company a “buy” rating in a research note on Tuesday, May 7th. Needham & Company LLC reaffirmed a “buy” rating and set a $400.00 target price on shares of Axon Enterprise in a report on Tuesday, May 7th. JPMorgan Chase & Co. upped their target price on Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a report on Thursday, April 11th. Morgan Stanley upped their target price on Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, April 26th. Finally, Barclays upped their target price on Axon Enterprise from $308.00 to $381.00 and gave the company an “overweight” rating in a report on Wednesday, May 8th. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and an average price target of $335.27.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 308 shares of the stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $310.07, for a total transaction of $95,501.56. Following the completion of the transaction, the director now directly owns 1,607 shares of the company’s stock, valued at approximately $498,282.49. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, Director Julie A. Cullivan sold 993 shares of the stock in a transaction on Friday, May 31st. The stock was sold at an average price of $281.72, for a total transaction of $279,747.96. Following the completion of the sale, the director now owns 4,553 shares in the company, valued at approximately $1,282,671.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jeri Williams sold 308 shares of the stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $310.07, for a total value of $95,501.56. Following the sale, the director now owns 1,607 shares of the company’s stock, valued at approximately $498,282.49. The disclosure for this sale can be found here. In the last ninety days, insiders sold 89,447 shares of company stock valued at $27,684,677. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Price Performance

NASDAQ AXON traded up $15.98 on Monday, reaching $308.64. 642,297 shares of the stock traded hands, compared to its average volume of 486,977. The firm’s fifty day simple moving average is $292.57 and its 200 day simple moving average is $287.98. The company has a quick ratio of 2.55, a current ratio of 2.91 and a debt-to-equity ratio of 0.37. The company has a market cap of $23.29 billion, a price-to-earnings ratio of 85.57 and a beta of 0.95. Axon Enterprise, Inc. has a 12 month low of $175.37 and a 12 month high of $329.87.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.20. The firm had revenue of $460.74 million during the quarter, compared to analyst estimates of $441.57 million. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The firm’s quarterly revenue was up 34.3% on a year-over-year basis. During the same period last year, the company posted $0.51 EPS. As a group, research analysts predict that Axon Enterprise, Inc. will post 2.35 EPS for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.